{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:25Z","timestamp":1792245745089,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11046-018-0287-0","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T05:34:15Z","timestamp":1532324055000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-8543","authenticated-orcid":false,"given":"Anna","family":"Pomorska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Malecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Jaworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Radon-Proskura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Kr\u00f8ger","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Vedel","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee O\u2019Brian","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Elvang","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninela","family":"Irga-Jaworska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"287_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF01878266","volume":"66","author":"P F\u00fcrbringer","year":"1876","unstructured":"F\u00fcrbringer P. Beobachtungen \u00fcber Lungenmycose beim Menschen. Arch f\u00fcr Pathol Anat und Physiol und f\u00fcr Klin Med. 1876;66:330\u201365.","journal-title":"Arch f\u00fcr Pathol Anat und Physiol und f\u00fcr Klin Med"},{"key":"287_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/jama.1952.03680160029007","volume":"150","author":"RD Baker","year":"1952","unstructured":"Baker RD. Resectable mycotic lesions and acutely fatal mycoses. J Am Med Assoc. 1952;150:1579\u201381.","journal-title":"J Am Med Assoc"},{"key":"287_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0179136","volume":"12","author":"J Guinea","year":"2017","unstructured":"Guinea J, Escribano P, Vena A, et al. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates. PLoS ONE. 2017;12:1\u201310.","journal-title":"PLoS ONE"},{"key":"287_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","volume":"16","author":"ZD Pana","year":"2016","unstructured":"Pana ZD, Seidel D, Skiada A, et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis. 2016;16:667.","journal-title":"BMC Infect Dis"},{"key":"287_CR5","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.1128\/AAC.01919-15","volume":"12","author":"MC Arendrup","year":"2015","unstructured":"Arendrup MC, Jensen RH, Meletiadis J. In vitro activity of isavuconazole and comparators against clinical isolates of the Mucorales order. Antimicrob Agents Chemother. 2015;12:7735\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"287_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<100::AID-PATH100>3.0.CO;2-O","volume":"181","author":"HE Jensen","year":"1997","unstructured":"Jensen HE, Salonen J, Ekfors TO. The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies. J Pathol. 1997;181:100\u20135.","journal-title":"J Pathol"},{"key":"287_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1699-0463.1996.tb00714.x","volume":"104","author":"HE Jensen","year":"1996","unstructured":"Jensen HE, Sch\u00f8nheyder HC, Hotchi M, Kaufman L. Diagnosis of systemic mycoses by specific immunohistochemical tests. APMIS. 1996;104:241\u201358.","journal-title":"APMIS"},{"key":"287_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.funbio.2015.04.007","volume":"120","author":"L Irinyi","year":"2016","unstructured":"Irinyi L, Lackner M, de Hoog GS, Meyer W. DNA barcoding of fungi causing infections in humans and animals. Fungal Biol. 2016;120:125\u201336.","journal-title":"Fungal Biol"},{"key":"287_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153:897\u2013905.","journal-title":"JAMA Dermatol"},{"key":"287_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MPH.0b013e3181ca0dcf","volume":"32","author":"BG Roux","year":"2010","unstructured":"Roux BG, M\u00e9chinaud F, Gay-Andrieu F, et al. Successful triple combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma. J Pediatr Hematol. 2010;32:131\u20133.","journal-title":"J Pediatr Hematol"},{"key":"287_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MPH.0b013e3181c2bdce","volume":"32","author":"J Garbino","year":"2010","unstructured":"Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol. 2010;32:85\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"287_CR12","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1111\/j.1399-3046.2010.01406.x","volume":"16","author":"TF Weng","year":"2012","unstructured":"Weng TF, Ho MW, Lin HC, et al. Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia. Pediatr Transplant. 2012;16:E35\u20138.","journal-title":"Pediatr Transplant"},{"key":"287_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1439-0507.2011.02025.x","volume":"54","author":"J D\u00e4britz","year":"2011","unstructured":"D\u00e4britz J, Attarbaschi A, Tintelnot K, et al. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases. Mycoses. 2011;54:785\u20138.","journal-title":"Mycoses"},{"key":"287_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/myc.12010","volume":"56","author":"A Phulpin-Weibel","year":"2013","unstructured":"Phulpin-Weibel A, Rivier A, Leblanc T, et al. Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases. Mycoses. 2013;56:236\u201340.","journal-title":"Mycoses"},{"key":"287_CR15","first-page":"35","volume":"49","author":"MJ Jos\u00e9 Gonz\u00e1lez-Abad","year":"2013","unstructured":"Jos\u00e9 Gonz\u00e1lez-Abad MJ, Alonso Sanz M. Zygomycosis in children: disseminated infection caused by Cunninghamella bertholletiae. Arch Bronconeumol. 2013;49:35.","journal-title":"Arch Bronconeumol"},{"key":"287_CR16","doi-asserted-by":"crossref","first-page":"bcr2013009577","DOI":"10.1136\/bcr-2013-009577","volume":"31","author":"C Guymer","year":"2013","unstructured":"Guymer C, Khurana S, Suppiah R, et al. Successful treatment of disseminated mucormycosis in a neutropenic patient with T-cell acute lymphoblastic leukaemia. BMJ Case Rep. 2013;31:bcr2013009577.","journal-title":"BMJ Case Rep"},{"key":"287_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0971-5851.125254","volume":"34","author":"A Gupta","year":"2013","unstructured":"Gupta A, Jain S, Agrawal C, Kapoor G. Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia. Indian J Med Paediatr Oncol. 2013;34:313\u20136.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"287_CR18","doi-asserted-by":"publisher","first-page":"E216","DOI":"10.1111\/tid.12144","volume":"15","author":"B Ye","year":"2013","unstructured":"Ye B, Yu D, Zhang X, et al. Disseminated Rhizopus microsporus infection following allogeneic hematopoietic stem cell transplantation in a child with severe aplastic anemia. Transpl Infect Dis. 2013;15:E216\u201323.","journal-title":"Transpl Infect Dis"},{"key":"287_CR19","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1097\/MPH.0b013e31829eec5a","volume":"36","author":"F Carceller","year":"2014","unstructured":"Carceller F, Onoro G, Buitrago MJ, et al. Cunninghamella bertholletiae infection in children: review and report of 2 cases with disseminated infection. J Pediatr Hematol Oncol. 2014;36:e109\u201314.","journal-title":"J Pediatr Hematol Oncol"},{"key":"287_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1297\/cpe.24.51","volume":"24","author":"D Dayal","year":"2015","unstructured":"Dayal D, Jain P, Kumar R, et al. Clinical spectrum and outcome of invasive filamentous fungal infections in children with type 1 diabetes: north Indian experience. Clin Pediatr Endocrinol. 2015;24:51\u20137.","journal-title":"Clin Pediatr Endocrinol"},{"key":"287_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s15010-015-0839-x","volume":"44","author":"MM Gerlach","year":"2016","unstructured":"Gerlach MM, Lippmann N, Kobelt L, et al. Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident. Infection. 2016;44:361\u20134.","journal-title":"Infection"},{"key":"287_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/ped.12866","volume":"58","author":"D Suzuki","year":"2016","unstructured":"Suzuki D, Kobayashi R, Hori D, et al. Stem cell transplantation for acute myeloid leukemia with pulmonary and cerebral mucormycosis. Pediatr Int. 2016;58:569\u201372.","journal-title":"Pediatr Int"},{"key":"287_CR23","doi-asserted-by":"publisher","first-page":"e5054","DOI":"10.1097\/MD.0000000000005054","volume":"95","author":"YM Seo","year":"2016","unstructured":"Seo YM, Hwang-Bo S, Kim SK, et al. Fatal systemic adenoviral infection superimposed on pulmonary mucormycosis in a child with acute leukemia: a case report. Med (Baltim). 2016;95:e5054.","journal-title":"Med (Baltim)"},{"key":"287_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MPH.0000000000000235","volume":"36","author":"AD Malkan","year":"2014","unstructured":"Malkan AD, Wahid FN, Rao BN, Sandoval JA. Aggressive Cunninghamella pneumonia in an adolescent. J Pediatr Hematol Oncol. 2014;36:581\u20132.","journal-title":"J Pediatr Hematol Oncol"},{"key":"287_CR25","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.3892\/ol.2016.4370","volume":"11","author":"XM Wang","year":"2016","unstructured":"Wang XM, Guo LC, Xue SL, Chen YB. Pulmonary mucormycosis: a case report and review of the literature. Oncol Lett. 2016;11:3049\u201353.","journal-title":"Oncol Lett"},{"key":"287_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/myc.12232","volume":"57","author":"AS Ibrahim","year":"2014","unstructured":"Ibrahim AS. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Mycoses. 2014;57:13\u20137.","journal-title":"Mycoses"},{"key":"287_CR27","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1172\/JCI32338","volume":"117","author":"AS Ibrahim","year":"2007","unstructured":"Ibrahim AS, Gebermariam T, Fu Y, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Investig. 2007;117:2649\u201357.","journal-title":"J Clin Investig"},{"key":"287_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/jac\/dkr375","volume":"67","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The deferasirox-AmBisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012;67:715\u201322.","journal-title":"J Antimicrob Chemother"},{"key":"287_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102:433\u201344.","journal-title":"Haematologica"},{"key":"287_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","volume":"16","author":"FM Marty","year":"2016","unstructured":"Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16:828\u201337.","journal-title":"Lancet Infect Dis"},{"key":"287_CR31","first-page":"79","volume":"9","author":"MA Donnelley","year":"2016","unstructured":"Donnelley MA, Zhu ES, Thompson GR. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infect Drug Resist. 2016;9:79\u201386.","journal-title":"Infect Drug Resist"},{"key":"287_CR32","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","volume":"76","author":"M Shirley","year":"2016","unstructured":"Shirley M, Scott LJ. Isavuconazole: a review in invasive aspergillosis and mucormycosis. Drugs. 2016;76:1647\u201357.","journal-title":"Drugs"},{"key":"287_CR33","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","volume":"387","author":"JA Maertens","year":"2016","unstructured":"Maertens JA, Raad II, Marr KA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387:760\u20139.","journal-title":"Lancet"},{"key":"287_CR34","doi-asserted-by":"publisher","first-page":"i12","DOI":"10.1093\/jac\/dkx029","volume":"72","author":"KE Stott","year":"2017","unstructured":"Stott KE, Hope WW. Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations. J Antimicrob Chemother. 2017;72:i12\u20138.","journal-title":"J Antimicrob Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-018-0287-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0287-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0287-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:18:58Z","timestamp":1720448338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-018-0287-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1007\/s11046-018-0287-0","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent for off-label isavuconazole administration was obtained from parents of our patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}